Campbell & Co. Investment Adviser »

Neurocrine Biosciences shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.8M 16k 115.22
2023-03-31 $1.0M 10k 101.22
2022-12-31 $489k 4.1k 119.44
2022-09-30 $635k 6.0k 106.22
2020-09-30 $772k 8.0k 96.15
2019-12-31 $2.5M 24k 107.50
2018-12-31 $246k 3.1k 78.97

More positions owned by Campbell & Co. Investment Adviser

Intercontinental Exchange In Common Stock (ICE)
Fastenal Common Stock (FAST)
Novartis Adr (NVS)
Hca Healthcare Common Stock (HCA)
Schwab Charles Corp Common Stock (SCHW)
Electronic Arts Common Stock (EA)
Elevance Health Common Stock (ELV)
Grainger W W Common Stock (GWW)
Packaging Corp Amer Common Stock (PKG)
Roper Technologies Common Stock (ROP)
Mondelez Intl Common Stock (MDLZ)
Aflac Common Stock (AFL)
Applied Matls Common Stock (AMAT)
Marketaxess Hldgs Common Stock (MKTX)
Ameriprise Finl Common Stock (AMP)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
State Street Corporation
Dodge & Cox
Citadel Advisors
Renaissance Technologies
AQR Capital Management
Geode Capital Management
Bellevue Group
Morgan Stanley
T. Rowe Price Associates
Wellington Management Company
Jpmorgan Chase & Co
Ubs Global Asset Management Americas
Goldman Sachs Group

View all funds holding Neurocrine Biosciences